These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 39445019)

  • 1. Prognostic modeling of hepatocellular carcinoma based on T-cell proliferation regulators: a bioinformatics approach.
    Hai L; Bai XY; Luo X; Liu SW; Ma ZM; Ma LN; Ding XC
    Front Immunol; 2024; 15():1444091. PubMed ID: 39445019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
    Wang S; Bai H; Fei S; Miao B
    Biochem Genet; 2024 Jun; 62(3):2332-2351. PubMed ID: 37898914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
    J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
    Yan Z; He M; He L; Wei L; Zhang Y
    Front Immunol; 2021; 12():723271. PubMed ID: 34925311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune system‑associated genes increase malignant progression and can be used to predict clinical outcome in patients with hepatocellular carcinoma.
    Huang R; Chen Z; Li W; Fan C; Liu J
    Int J Oncol; 2020 May; 56(5):1199-1211. PubMed ID: 32319580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A m
    Xu S; Zhang Y; Yang Y; Dong K; Zhang H; Luo C; Liu SM
    Front Immunol; 2024; 15():1374465. PubMed ID: 39119345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
    Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J
    Front Immunol; 2024; 15():1244392. PubMed ID: 38694506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J
    Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
    Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J
    BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification.
    Ouyang G; Li Q; Wei Y; Dai W; Deng H; Liu Y; Li J; Li M; Luo S; Li S; Liang Y; Pan G; Yang J; Gan T
    Front Immunol; 2024; 15():1323199. PubMed ID: 38742112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
    Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X
    Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
    Mo Z; Liu D; Rong D; Zhang S
    Front Immunol; 2021; 12():611058. PubMed ID: 33679749
    [No Abstract]   [Full Text] [Related]  

  • 15. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma.
    Dai Y; Qiang W; Lin K; Gui Y; Lan X; Wang D
    Cancer Immunol Immunother; 2021 Apr; 70(4):967-979. PubMed ID: 33089373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pyroptosis-Based Prognostic Model for Immune Microenvironment Estimation of Hepatocellular Carcinoma.
    Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Jin H; Shi N
    Dis Markers; 2022; 2022():8109771. PubMed ID: 35047095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of N
    Zhu HX; Lu WJ; Zhu WP; Yu S
    J Clin Lab Anal; 2021 Dec; 35(12):e24071. PubMed ID: 34741346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
    Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X
    J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma.
    Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y
    Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma.
    Chen H; Li Y; Xiao SY; Guo J
    BMC Cancer; 2021 Mar; 21(1):278. PubMed ID: 33726698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.